CUSIP: 603693102
Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
1,336,901
-
Share change
-
+1,336,901
-
Total reported value
-
$5,963,000
-
Price per share
-
$4.46
-
Number of holders
-
20
-
Value change
-
+$5,963,000
-
Number of buys
-
20
Quarterly Holders Quick Answers
What is CUSIP 603693102?
CUSIP 603693102 identifies INKT - MiNK Therapeutics, Inc. - Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 603693102:
Institutional Holders of MiNK Therapeutics, Inc. - Stock (INKT) as of Q4 2021
As of 31 Dec 2021,
MiNK Therapeutics, Inc. - Stock (INKT) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,336,901 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, Sofinnova Investments, Inc., Artal Group S.A., MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, Gyon Technologies Capital Management, LP, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, Invesco Ltd., and STATE STREET CORP.
This page lists
20
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.